Innospec Inc.

IOSP Basic Materials Specialty Chemicals

Innospec Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.8 billion, down 3.65% from fiscal 2024. In the quarter to June 2026, revenue grew 11.8%, EPS grew 33.0% and free cash flow fell 63.2%, each against the same quarter a year earlier. Dividend growth for ten consecutive years; insiders bought in the last twelve months.

96.81 0.21 +0.22%
Market cap
$2.4B
P/E
19.7×
Fwd P/E
16.3×
Dividend yield
1.85%
F-score
7/9
Altman Z
4.75
Beneish M
−2.46
Dividend safety
79/100

Insider Decisions trades per month

Total buys 0.03
Total sells 0.57
Totals in millions of $.
Dec 25 Mar 26 Jun 26 Sep 26
Buy 1 — — — — — — — — — — —
Sell — — — 7 1 — — — — — — —
Insider Ownership 1.60%

Capital & Financial Ratios $m

Market Cap 2,380.00
Revenue 1,842.10
Net Income 121.10
Free Cash Flow 51.40
Net Debt (250.20)
Current Ratio 2.78 (at or above 1.5: strong)
Debt/Equity 0.00 (at or below 0.5: strong)
P/E ratio 19.72
Fwd P/E 16.30
P/S ratio 1.30
P/B ratio 1.77
Past 5Y EPS Growth 32.12% (at or above 15%: strong)
This Y EPS Growth (6.64%) (below 0%: weak)
Next Y EPS Growth 25.34% (at or above 15%: strong)
Next Y revenue growth 7.14%
Next 5Y EPS Growth 2.26%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

P/E against its own 10 years 36.09%
10-year low 10-year high
P/S against its own 10 years 36.60%
10-year low 10-year high
P/B against its own 10 years 16.26%
10-year low 10-year high
EV/Sales against its own 10 years 21.56%
10-year low 10-year high
EV/FCF against its own 10 years 81.02%
10-year low 10-year high

Dividends

Payout Ratio 0.37
Annual Dividend Rate 1.79
Annual Dividend Yield 1.85%
total individual payouts
2027 Powerpack
2026 1.89
0.92
2025 1.71
0.84
0.87
2024 1.55
0.76
0.79
2023 1.41
0.69
0.72
2022 1.28
0.63
0.65
2021 1.16
0.57
0.59
2020 1.04
0.52
0.52
2019 1.02
0.50
0.52
2018 0.89
0.44
0.45
2017 0.77
0.38
0.39
2016 0.67
0.33
0.34
predictions special payouts not included in total or ratios

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 204 289 293 250
Receivables 360 342 342 409
Inventory 300 301 329 337
Other 1 1 7 10
886 957 1,005 1,025
2023 2024 2025 Q'26
Payables 164 164 175 169
ST’ Debt — — — —
Other 5 5 12 8
372 371 360 368

Compound Annual Growth %

10y 5y 3y
Sales 5.79% 8.31% (3.26%)
Cash Flow 1.58% (1.06%) 19.18%
Earnings (0.25%) 32.36% (4.29%)
Book Value 8.21% 7.12% 8.61%

Revenue $m

Mar Jun Sep Dec Year
’26 453 491 — — —
’25 441 440 442 456 1,778
’24 500 435 443 467 1,845
’23 510 480 464 495 1,949
’22 472 468 513 511 1,964
’21 340 355 376 413 1,483
’20 372 245 265 311 1,193
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 18 7 — — —
’25 28 11 38 61 138
’24 81 5 74 26 185
’23 22 55 58 72 207
’22 (29) (7) 40 78 82
’21 23 (1) 3 69 93
’20 2 30 56 58 146
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 4 (9) — — —
’25 13 (6) 16 41 64
’24 66 (10) 62 5 123
’23 0 38 41 51 130
’22 (37) (16) 30 63 40
’21 12 (10) (5) 60 57
’20 (5) 23 48 50 116
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 1.22 1.25 — — —
’25 1.31 0.94 0.52 1.91 4.67
’24 1.65 1.24 1.33 (2.80) 1.42
’23 1.33 1.16 1.57 1.51 5.56
’22 1.46 1.29 1.55 1.02 5.32
’21 0.94 0.90 0.94 0.96 3.75
’20 1.34 (1.62) 0.51 0.91 1.16
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 2026e 2027e 2028e
Price, $
Price, $ Low 41.61 54.10 53.07 56.94 56.71 81.00 83.13 91.74 103.97 70.10

Analyst estimates 2026–2028

Powerpack
High 73.40 74.75 83.20 107.10 107.85 107.73 115.66 125.87 133.71 117.08
People
People Employees 1,800 1,900 2,000 2,000 1,900 1,900 2,100 2,400 2,450 2,450
Revenue/emp, $m 0.49 0.69 0.74 0.76 0.63 0.78 0.94 0.81 0.75 0.73
Income, $m
Income, $m Revenue 883 1,307 1,477 1,513 1,193 1,483 1,964 1,949 1,845 1,778
Gross margin, % 37.62 30.86 29.45 30.81 28.72 29.32 29.88 30.33 29.42 27.69
EBT 103 128 132 150 40 134 185 174 41 138
EBT margin, % 11.67 9.80 8.91 9.94 3.33 9.06 9.40 8.95 2.23 7.77
Net income 81 62 85 112 29 93 133 139 36 117
Depreciation 38 50 50 48 66 43 40 39 44 44
Per share, $
Per share, $ Revenue 36.81 54.12 60.53 61.81 48.57 60.19 79.22 78.42 74.02 71.46
Earnings 3.39 2.56 3.48 4.58 1.17 3.78 5.37 5.60 1.43 4.69
Cash flow 4.40 3.42 4.30 6.60 5.94 3.78 3.30 8.34 7.40 5.56
Capex (0.69) (1.33) (1.23) (1.27) (1.21) (1.47) (1.70) (3.10) (2.48) (2.99)
Free cash flow 3.71 2.09 3.07 5.33 4.73 2.31 1.60 5.24 4.92 2.57
Book value 27.24 32.89 33.83 37.53 38.47 41.91 41.97 46.26 48.78 53.57
Shares, m 24 24 24 24 25 25 25 25 25 25
Valuation, ×
Valuation, × P/E 20.44 27.81 17.75 22.59 77.55 23.90 19.32 21.82 76.97 16.35
P/S 1.89 1.32 1.02 1.67 1.87 1.50 1.31 1.56 1.49 1.07
P/B 2.55 2.16 1.83 2.76 2.36 2.16 2.47 2.64 2.26 1.43
EV/Sales 2.08 1.42 1.08 1.68 1.80 1.42 1.24 1.46 1.34 0.92
EV/FCF 22.11 36.65 21.30 19.43 18.64 37.68 61.64 21.92 20.18 25.56
Cash, $m
Cash, $m Operating cash flow 106 83 105 162 146 93 82 207 185 138
Capex (16) (32) (30) (31) (30) (36) (42) (77) (62) (74)
Free cash flow 89 51 75 131 116 57 40 130 123 64
Balance, $m
Balance, $m Working capital 258 300 367 327 314 392 467 514 585 645
Total debt 272 222 209 59 0 36 45 — — —
Net debt 170 131 86 (17) (105) (142) (147) (204) (289) (292)
Shareholders’ equity 654 794 826 919 945 1,033 1,040 1,150 1,216 1,333
Returns, %
Returns, % ROA 7.36 4.77 5.90 7.63 2.00 6.27 8.38 8.40 2.07 6.54
ROIC 7.45 8.44 9.15 10.38 2.51 9.26 13.10 10.68 12.00 7.78
ROE 12.91 8.54 10.50 12.86 3.08 9.41 12.83 12.70 3.01 9.15
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Innospec Inc. vs peers in Specialty Chemicals (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
ASH Ashland Inc. $3.3B 62.4× 24.9× +7.34% (above 0%: growing) n/m +5.26% (above 0%: growing) 34.21% 8.65% Compare
FUL H. B. Fuller Company $2.8B 14.1× 16.8× +5.17% (above 0%: growing) +18.19% (above 0%: growing) −58.41% (below 0%: shrinking) 33.22% 12.07% Compare
HWKN Hawkins, Inc. $2.8B 33.8× 36.3× +7.64% (above 0%: growing) −3.55% (below 0%: shrinking) +30.29% (above 0%: growing) 23.44% 12.25% Compare
KWR Quaker Houghton $2.7B 27.9× 25.2× +10.17% (above 0%: growing) n/m −43.19% (below 0%: shrinking) 35.53% 7.62% Compare
WDFC WD-40 Company $2.7B 30.3× 34.0× +24.35% (above 0%: growing) +45.45% (above 0%: growing) −13.28% (below 0%: shrinking) 56.59% 20.67% Compare
NGVT Ingevity Corporation $2.4B 45.3× 18.5× −5.25% (below 0%: shrinking) n/m −136.08% (below 0%: shrinking) 44.25% 19.13% Compare
IOSP Innospec Inc. $2.4B 19.7× 16.3× +11.76% (above 0%: growing) +32.98% (above 0%: growing) −63.16% (below 0%: shrinking) 28.14% 8.08%
MTX Minerals Technologies Inc. $2.0B — (loss-making) 12.4× +3.69% (above 0%: growing) n/m +5.92% (above 0%: growing) 24.40% (40.17%) Compare
CC The Chemours Company $1.9B — (loss-making) 16.9× −1.49% (below 0%: shrinking) n/m +128.00% (above 0%: growing) 17.98% (13.39%) Compare
Median of peers $2.7B 32.1× 21.7× +6.26% +18.19% −4.01% 33.72% 10.36%

All 60 Specialty Chemicals stocks →

Innospec Inc. (IOSP) key facts

  • Concern: Innospec Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.8 billion, down 3.65% from fiscal 2024.
  • Innospec Inc. (IOSP) is a Specialty Chemicals company in the Basic Materials sector, listed on Nasdaq.
  • As of October 16, 2026, IOSP traded at $96.81, a market capitalization of $2.4 billion.
  • Innospec Inc. pays an annual dividend of $1.79 per share, a yield of 1.85%, with a payout ratio of 36.5%.
  • Return on equity was 9.15% and debt-to-equity 0.00.
  • Its Piotroski F-score is 7 out of 9 and its Altman Z-score is 4.75 (safe zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.

Innospec Inc. (IOSP) Latest News

12 Aug

Impact 3 · transcript
stockrow.com/IOSP · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com